Background: The intraglandular application of botulinum neurotoxin type A (BoNT-A) is used in patients with neuromotor disorders to control the escape of saliva. The aim of this study was to analyze the impact of repeated treatment with BoNT-A on the submandibular-sublingual complex of rats.
Methods: A total of 35 Wistar rats were divided into three groups: control group (C), in which animals were not treated; group B, treated with 2.5 U intraglandular injections of BoNT-A (Prosigne ) and group G, that received bovine gelatine (Prosigne stabilizer). Three applications were performed in intervals of 35 days. Twelve and 35 days after ending the treatment, submandibular-sublingual complex was collected for histological analysis. Immunohistochemical reactions for calponin and specific muscle actin were also performed, besides detection of apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay.
Results: A decrease in mucosal and serous acini diameter was observed, with increased interstitial space after 12 days of treatment with BoNT-A, which was observed in a lesser degree on the 35th day. At 12 days, immunohistochemical analysis revealed a decrease in myoepithelial cells of serous acini in group B. TUNEL methods evidenced apoptosis in animals from group B.
Conclusions: BoNT-A caused histological and cellular changes in submandibular-sublingual complex, followed by a tendency toward reversal after 35 days. The reversal characteristic of cellular changes in the submandibular-sublingual complex suggests that this BoNT-A formulation may be safely used for sialorrhea treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/jop.12887 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Human Serum and Salivary Metabolomes: Diversity and Closeness.
Int J Mol Sci
November 2023
Laboratory of Biochemistry and Metabolomics, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
Article Synopsis
- Saliva is a promising resource for identifying health biomarkers because it reflects an individual's health status and has molecular links to blood due to the salivary glands' high vascularization.
- This study investigated the relationships between metabolite profiles in saliva and serum using samples from 20 healthy young individuals, employing advanced H-NMR spectroscopy and statistical analyses.
- Findings indicate that while there are correlations between serum and saliva metabolites, saliva's complex composition and oral metabolism mean it cannot be seen as merely a filter of blood, highlighting its importance for laboratory diagnostics.
Effects of chronic treatment with botulinum toxin type A in salivary glands of rats: Histological and immunohistochemical analyses.
J Oral Pathol Med
September 2019
Department of Clinical and Preventive Dentistry, School of Dentistry, Universidade Federal de Pernambuco, Recife, Brazil.
Background: The intraglandular application of botulinum neurotoxin type A (BoNT-A) is used in patients with neuromotor disorders to control the escape of saliva. The aim of this study was to analyze the impact of repeated treatment with BoNT-A on the submandibular-sublingual complex of rats.
Methods: A total of 35 Wistar rats were divided into three groups: control group (C), in which animals were not treated; group B, treated with 2.
Normal Values for Parotid Gland and Submandibular-Sublingual Salivary Gland Complex Uptake of 99mTechnetium Pertechnetate using SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm.
Nuklearmedizin
February 2019
Berlin Experimental Radionuclide Imaging Center (BERIC), Charité - Universitätsmedizin Berlin.
Aim: The aim of this study was to establish normal values for parotid gland (PG) and submandibular-sublingual salivary gland complex (SSC) uptake of technetium pertechnetate (TcO) as a function of age, sex and circadian rhythm in mice.
Methods: In 12 female (F) and 12 male (M) C57BL/6N mice, nine consecutive SPECT images of 10 min each were acquired as dynamic acquisitions beginning 5 min after intravenous injection of 80 MBq TcO. Each mouse was imaged in follow-up studies at 1, 3, 6, 12 and 24 months of age.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!